Day One Biopharmaceuticals, Inc.·4

Jun 23, 6:11 PM ET

Josey John A. 4

4 · Day One Biopharmaceuticals, Inc. · Filed Jun 23, 2022

Insider Transaction Report

Form 4
Period: 2022-06-21
Transactions
  • Award

    Director Stock Option (Right to buy Common Stock)

    2022-06-21+28,70028,700 total
    Exercise: $16.29Exp: 2032-06-20Common Stock (28,700 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/12th of the total shares on each monthly anniversary, beginning on July 21, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION